Siga Technologies INC Other Liabilities
Siga Technologies INC (SIGA) had Other Liabilities of $3.20 million as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OtherLiabilities · last filed 2025-03-11
- 2024-12-31: Other Liabilities $3.20M.
- 2024-09-30: Other Liabilities $3.61M.
- 2024-06-30: Other Liabilities $3.72M.
- 2024-03-31: Other Liabilities $3.34M.
| Period end | Other Liabilities | Other Liabilities as first filed |
|---|---|---|
| 2024-12-31 | $3.20M 10-K · filed 2025-03-11 | |
| 2024-09-30 | $3.61M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.72M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $3.34M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $3.38M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $3.50M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $3.45M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.35M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $3.36M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $3.63M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $3.48M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $3.40M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.40M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $3.72M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.72M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.85M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.92M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $3.13M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.97M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.87M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $2.93M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $3.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.32M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.53M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $1.26M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $903.95K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $704.86K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $774.13K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $840.25K 10-K · filed 2019-03-06 | |
| 2017-09-30 | $844.41K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $238.32K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $225.82K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $247.99K 10-K · filed 2018-03-06 | |
| 2016-09-30 | $269.05K 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $290.10K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $311.16K 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $332.22K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $351.89K 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $371.56K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $389.84K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $405.32K 10-K · filed 2016-03-04 | |
| 2014-09-30 | $415.89K 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $426.46K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $437.04K 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $447.61K 10-K · filed 2015-03-06 | |
| 2013-09-30 | $454.24K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $348.13K 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $167.09K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $166.30K 10-K · filed 2014-03-10 | |
| 2012-09-30 | $59.56M 10-K/A · filed 2013-05-15 | $161.98K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $57.66M 10-K/A · filed 2013-05-15 | $157.18K 10-Q · filed 2012-08-06 |
| 2012-03-31 | $50.02M 10-K/A · filed 2013-05-15 | $152.38K 10-Q · filed 2012-05-07 |
| 2011-12-31 | $147.59K 10-K/A · filed 2013-05-15 | |
| 2011-09-30 | $3.78M 10-K/A · filed 2013-05-15 | $83.70K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $3.27M 10-K/A · filed 2013-05-15 | $20.93K 10-Q · filed 2011-08-01 |
| 2011-03-31 | $3.47M 10-K/A · filed 2013-05-15 | |
| 2010-12-31 | $0.00 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |